NCT01537991View on ClinicalTrials.gov

ISoToxic Accelerated RadioTherapy in Locally Advanced Non-small Cell Lung Cancer: The Phase I/II I-START Trial

NACompletedINTERVENTIONAL
Enrollment

81

Participants

Timeline

Start Date

January 26, 2012

Primary Completion Date

April 11, 2016

Study Completion Date

December 31, 2018

Conditions
Locally Advanced Non-small Cell Lung Cancer
Interventions
RADIATION

Radiotherapy

All patients will receive radiotherapy to the primary lung tumour and any demonstrated nodal involvement. Patients will be given radiotherapy of a dose between 58 and 65Gy in 20 fractions. Dose will be determined by the patients' group.

Trial Locations (2)

CF14 2TL

Velindre Cancer Centre, Cardiff

CH63 4JY

Clatterbridge Centre for Oncology, Liverpool

All Listed Sponsors
lead

Lisette Nixon

OTHER_GOV

NCT01537991 - ISoToxic Accelerated RadioTherapy in Locally Advanced Non-small Cell Lung Cancer: The Phase I/II I-START Trial | Biotech Hunter | Biotech Hunter